Condition: Non-Small-Cell Lung Cancer · Brain Metastases · Sponsor: The First People's Hospital of Lianyungang
To evaluate the efficacy and safety of SRT combined with anlotinib in the treatment of limited brain metastases from non-small cell lung cancer.
This description comes directly from the study's public registry record.
Xiaodong Jiang, Doc · 86-0518-85469074 · jxdysy1970@163.com
Xiaodong Jiang, Doc · 18961326201 · jxdysy1970@163.com
Always discuss trial participation with your own doctor first.
| The First People's Hospital of Lianyungang | Lianyungang, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06476093